Prevalence of the metabolic syndrome in a rural Turkish population: Comparison and concordance of two diagnostic criteria

Turkish Journal of Medical Sciences

Volumn 38, Issue 2, 2008, Pages 159-165

  Gemalmaz, Ayfer ^a   Aydin, Serpil ^a   Başak, Okay ^a   Disçigil, Güzel ^a   Karul, Aslihan ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Definitions; Metabolic syndrome; Prevalence; Turkish

Indexed keywords

BIOLOGICAL SYSTEMS; METABOLISM; POPULATION DYNAMICS;

METABOLIC SYNDROME (MES); PREVALENCE;

LIVING SYSTEMS STUDIES;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PREVALENCE; RURAL POPULATION; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

EID: 44149103188     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156:1070-7.
3. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153-9.
4. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003; 26: 861-7.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
6. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorola K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-76.
7. Onat A, Hergenç G, Can G. Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition. Anadolu Kardiyol Derg 2007; 7: 29-34.
8. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
9. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-97.
10. Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva: World Health Organization; 1991.
11. NHBLI Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: clinical guidelines on identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6: 51S-209S.
12. Son le NT, Kunii D, Hung NT, Sakai T, Yamamoto S. The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res Clin Pract 2005; 67: 243-50.
13. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, Celik S. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61: 548-53.
14. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 2006; 23: 441-4.
15. DECODA Study Group. Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the ATPIII definition. Diabetes Res Clin Pract 2007; 76: 57-67.
16. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults - a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60: 199-204.
17. Onat A. Lipids, lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease. Anadolu Kardiyol Derg 2004; 4: 236-45.
18. Kim ES, Han SM, Kim YI, Song KH, Kim MES, Kim WB et al. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 2004; 21: 1141-3.
19. Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN et al; MetS-Greece Collaborative Group. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005; 7: 397-405.
20. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH: Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005; 67: 251-7.
21. Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K; Greenland Population Study. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabet Med 2004; 21: 1237-42.
22. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY et al. High prevalence of metabolic syndrome in Hong Kong Chinese - comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005; 69: 160-8.
23. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications 2007; 21: 214-9.
24. Onat A, Sansoy V. Metabolic syndrome, major culprit of coronary disease among Turks: its prevalence and impact on coronary risk. Türk Kardiyol Dern Arş 2002; 30: 8-15 (article in Turkish).
25. Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-92.
26. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007; 77: 251-7.
27. Ko GT, Cockram CS, Chow CC, Yeung VT, Chan WB, So WY et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 2006; 73: 58-64.
28. Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J; International Diabetes Federation. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 2007; 56: 552-8.
29. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) 2007; 31: 528-34.